American company IBM, the manufacturer of artificial intelligence and software, continues to use its developments to fight cancer. The company entered into cooperation with the U.S. Department of Veterans Affairs, according to which, Watson's artificial intelligence will analyze the state of soldiers with the disease, especially of seriously ill patients in the latter stages. Watson will be used to analyze data and to study the point mutations of tumors in the body. IBM is confident that Watson will increase longevity of patients.
Over the past few days, IBM shares have increased by 4.1% and will continue to grow based on today's news. Trading will be available during the American session, from 13:40 to 20:00 GMT.
The information and recommendations contained in this analytical document are published strictly for information purposes and are not considered as an offer to buy or sell the trading tools mentioned above and are not intended to motivate to perform certain transactions